Beyond Monitoring

1. Remote Patient Monitoring (RPM) is often framed as a cornerstone of value-based care. From your perspective, how is RPM reshaping care delivery models in Europe compared to traditional episodic care?

Remote Patient Monitoring (RPM) is transforming European care models from episodic, in-clinic visits to continuous, team-based management. It provides care teams with valuable data on a patient's health between appointments, not just during the window of the visit, enabling a more accurate diagnosis and personalised treatment plans. By continuously tracking biomarkers, RPM allows for early intervention, which helps to prevent hospitalisations and reduce healthcare costs.

The rise of digital hospitals in Europe is shifting care to the home whenever possible. This leads to shorter inpatient stays, fewer urgent visits, and better-coordinated care between hospitals, general practitioners, and community nurses.

RPM also delivers significant value in follow-up care, particularly for rehabilitation, by adjusting the treatment plan, or for cancer patients, by helping to detect relapse early.

2. What are the most promising technologies driving the next generation of RPM devices, and how are they improving the accuracy, usability, and scalability of remote care?

RPM devices are rapidly evolving, becoming less invasive and more integrated into daily life. This is driven by next-generation wearables, including:

● Smart rings and earrings that track an increasing number of biomarkers
● Oral sensors to monitor saliva and medication efficiency
●  Innovative patches to track metabolic biomarkers through sweat or monitor bladder fullness without the need to do a blood test or an ultrasound

These technologies are enabling the continuous monitoring of complex metrics, from hydration and stress to respiration and blood oxygen saturation. 

It is made possible by key advancements that include:

● Medical-grade sensors that are moving from consumer-grade accuracy to clinical-grade precision.
●  Non-contact and ambient sensing, which eliminates the need for patients to wear a device at all.
● Low-power chips to extend battery life. 
● The expansion of 5G networks to enable seamless data uploads, enhancing scalability.

3. Integration with existing hospital information systems and EHR platforms remains a challenge. How should healthcare organisations strategically approach interoperability to maximise RPM’s benefits?

To maximise RPM’s benefits, interoperability with healthcare systems is key. Healthcare organisations should look at integration as a strategic priority, fostering close collaboration between clinical and IT teams to align medical needs with technical readiness.

Healthcare systems should establish and share technical requirements like standards for data formats, security, and workflow integration, with RPM vendors from the beginning. This proactive approach ensures faster integration, smoother adoption and allows data to flow seamlessly into EHRs. It results in more actionable insights for care teams, better and faster continuity for patients, and stronger outcomes across the care pathway.

4. In rural or underserved regions, where healthcare access is limited, how can RPM devices realistically bridge the care gap without overburdening existing resources?

In rural or underserved regions, particularly, RPM helps extend care by monitoring chronic patients from their home, reducing hospital visits and anticipating health issues before they escalate. In Galicia (Spain), a regional nurse-led program monitoring chronic and acute patients in rural areas has shown improved biometrics and great satisfaction: 86% of the 700 participants reported improved quality of life.

In underserved areas, eye checks or gynecological screenings can be performed by community health workers or nurses visiting patients where they are, with results analysed remotely by specialists. Patients who need further medical attention are referred to the closest medical centre. Those programs ensure early detection, prevent late-stage disease, and expand access without overwhelming resources, relying on collaborative and local care teams.

Reliability and simplicity are key for RPM to work in those areas —devices with embedded cellular connectivity and long battery life avoid infrastructure barriers.

5. Data security and patient privacy are critical concerns. What frameworks or innovations are emerging to ensure compliance with European data protection regulations like GDPR while enabling seamless RPM adoption?

To ensure patient privacy and data security, several key frameworks are emerging to ensure compliance with GDPR:

● Privacy by Design: Systems are built to minimise data collection and use default encryption from the beginning.
● End-to-End Encryption: All data transmitted is secured, ensuring it remains unreadable to unauthorised parties.
● Secure Cloud Infrastructure: Platforms use certified cloud services adhering to European data sovereignty rules.
● Federated Learning: AI algorithms are trained on data that does not leave the patient's device or the hospital's secure server, preserving privacy and enabling access to more data.
● Granular Consent Management: Patients are given easy-to-use tools to control which data they share and with whom.

6. What role do AI and predictive analytics play in interpreting continuous patient data streams, and how are they helping clinicians move from reactive to proactive care models?

AI and predictive analytics enhance RPM solutions by helping clinicians triage and prioritise patients, focusing on what matters most. They unify and interpret large volumes of data from multiple devices, and when combined with genetic profiles and lab results, AI can create a digital twin of the patient to identify risks, enable early detection and create personalised prevention programs.

To reduce alert fatigue, AI alerts clinicians only when immediate attention is needed. By providing a strong, integrated data foundation, AI enables informed decisions, timely responses, and more efficient patient management, while taking workload off from healthcare teams and improving the effectiveness of continuous care models.

7. How do reimbursement models and payer policies in Europe influence the pace and scale of RPM device adoption? Are current frameworks sufficient to support widespread use?

Reimbursement frameworks are pivotal to RPM adoption in Europe. Countries like Germany and France have been leading the way with structured programs, such as Germany's Diga or France’s List of Medical Telemonitoring Activities (LATM), which provides monthly payments to both RPM manufacturers and healthcare providers. Clear reimbursement and incentives accelerate adoption, while in countries without them, pilots don’t scale easily.

However, having reimbursement in place doesn’t equal adoption. Training and educating healthcare professionals is key for them to understand when and how to prescribe RPM effectively.

Private insurers are also driving uptake, increasingly bundling RPM into their packages to attract and retain customers, especially the younger, digital-savvy patients.

8. Could you share insights into how RPM devices are impacting patient engagement and adherence, particularly for chronic disease management?

RPM solutions are transforming chronic disease management by empowering patients to actively engage in their care. Through feedback loops and gentle nudges, patients receive concrete, actionable insights that help them track progress, reach goals, and improve their conditions.

By sharing bite-sized educational content, RPM also supports patients’ understanding of their disease, which enhances both engagement and adherence. This combination of real-time feedback and ongoing education fosters better self-management, encourages earlier symptom reporting, and supports proactive care.

RPM not only strengthens the patient’s role in their health journey but also delivers measurable improvements in disease control and overall quality of life.

9. From a clinical workflow standpoint, what are the most significant barriers healthcare professionals face in adopting RPM, and how can these be addressed through design or training?

Healthcare professionals face several workflow barriers when adopting RPM:

● Data overload: large volumes of data coming from multiple devices.
● Digital literacy gaps: uneven ability of the care team members to use digital tools and interpret data.
● Fragmented workflows: switching between RPM platforms and EHRs to enter and review data.
● Extra workload: Additional time reviewing and interpreting data, creating a new, time-consuming responsibility.

RPM providers should develop solutions that include:

● Involving and co-creating solutions with clinicians to address real unmet needs.
● Comprehensive training on usage and interpretation.
● Seamless EHR integration for automatic data flow.
● Intelligent alert systems with prioritisation of patients.
● Automating patient reminders, routine messages and nudges.

10. How can RPM solutions be tailored to the unique needs of multi-morbidity patients, where simultaneous monitoring of multiple conditions is required?

RPM can be very valuable for patients with co-morbidities who are often using several devices to manage their different conditions. By aggregating and synthesising data from diverse devices, apps, and surveys, RPM solutions can offer a holistic view of the patient’s health, reducing fragmentation and duplication while simplifying the experience for the patients and increasing their adherence.

For major effectiveness, clinical workflows should be redesigned to support multidisciplinary teams with harmonised and cross-functional escalation protocols. RPM dashboards should be personalised so specialists only have access to the information that matters to them without being overwhelmed. The main coordinator (e.g., nurse or coach) has access to all the data and can escalate issues when needed.

11. Partnerships between device manufacturers, healthcare providers, and technology companies are increasingly common. What collaboration models have proven most effective in scaling RPM deployment?

Partnerships between device manufacturers, healthcare providers, and technology companies are increasingly common. The most effective RPM collaboration models are those that align incentives, integrate seamlessly, and support the patient journey.

Partnerships thrive when solutions answer a real clinical unmet need and integrate smoothly without disrupting clinical workflows. Success also depends on designing technology that patients can easily embed into their daily lives, preventing drop-off and enabling scale.

A clear business model is essential, one that reflects the priorities of all partners involved. Past collaborations have struggled when innovations, despite offering clinical value, drove up treatment costs, which hindered adoption. To prevent this, risk-sharing models can provide a balanced approach, ensuring that incentives are aligned and benefits are distributed fairly across stakeholders.

12. Considering cost-effectiveness, how do you measure ROI for healthcare systems implementing RPM, beyond just reduced readmissions?

In terms of cost-effectiveness, RPM enables healthcare systems to assess ROI through multiple dimensions:

● Healthcare professional efficiency: Time saved on manual data entry, patient check-ins, and follow-ups.
● Resource optimisation: Treating more patients with the same or fewer staff.
● Care coordination: Streamlined communication between clinicians improves workflow and patient management.
● Post-care management: Earlier discharge and better post-procedure monitoring from home reduce downstream complications and hospital readmissions.
● Patient outcomes: Improved adherence and health results, leading to long-term cost savings.
● Patient satisfaction & retention: Enhanced experience can attract and retain patients, particularly in private systems.

13. With Europe’s aging population and rising prevalence of chronic diseases, where do you see the greatest untapped potential for RPM adoption in the next 5 - 10 years?

With Europe’s aging population and a growing shortage of healthcare professionals, especially in nursing and geriatric care, RPM will enable monitoring more patients with fewer resources, letting clinicians focus on those who need care most. Early symptom detection and proactive management can prevent deterioration and improve long-term health.

In geriatric institutions, RPM could support better oversight, reducing falls, complications, and hospitalisations through non-invasive solutions like radar or ballistocardiography technologies already used in Korean institutions.

Smart homes are growing and offer another opportunity. Connected devices like smart mirrors, smart mats, under-bed sensors, and even smart fridges could integrate RPM into daily environments, collecting a large amount of data to track early signs of deterioration.

14. Looking ahead, how do you envision RPM devices evolving - from standalone tools to integrated ecosystems that enable personalised, predictive, and preventive healthcare?

RPM devices are evolving from standalone tools into integrated ecosystems embedded into patients’ daily lives and fully part of the care routine. Future devices will be more powerful, accurate, and unobtrusive. Integrated with genomics and other health data, RPM will enable personalised prevention and treatment plans based on individual risk profiles.

Programs like Roussy’s cancer prevention model or Sanitas’s genomic program illustrate how RPM can become part of a holistic, predictive, and preventive healthcare approach, improving outcomes and optimising clinical workflows.

AI will play an increasing role: AI algorithms and agents will detect subtle health changes, trigger early alerts, and support healthcare professionals with actionable insights.

Humans will remain in the loop to guide patients, ensuring adherence and proactive care.

References:

https://corporativo.sanitas.es/mi-salud-genomica/
https://www.gustaveroussy.fr/en/interception
https://gnius.esante.gouv.fr/en/financing/reimbursement-profiles/remote-monitoring-reimbursement
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://health.ec.europa.eu/system/files/2021-12/ev_20210601_co05_en.pdf

--Issue 06--